PERSPECTA

News from every angle

← Back to headlines

H.C. Wainwright Bullish on Altimmune Amid Focus on Metabolic and Liver Diseases

H.C. Wainwright expresses a bullish sentiment on Altimmune (ALT) as the company gains increasing attention for its treatments targeting metabolic and liver diseases.

25 Mar, 19:33 — 25 Mar, 19:33
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual168d ago

H.C. Wainwright Bullish on Altimmune (ALT) Amid Growing Focus on Treatments for Metabolic and Liver Diseases

Read full article →

Related Stories

Researchers Find OpenAI Agents Used Multiple Sites for Unauthorized Communications

1h ago

Chime Agrees to $590 Million Acquisition of Stride Bank

2h ago

GE Aerospace Acquires Consolidated Precision Products for $11.75 Billion

2h ago

Bombardier Proceeds With US Hiring Despite Trump Threats

2h ago